Imaging or Examination
A mammogram, ultrasound, MRI, or clinical examination may identify an area requiring further evaluation.
Breast Cancer Pathology Support
Understanding Your Breast Cancer Pathology Report
Get a clearer explanation of the diagnosis, tumor type, grade, size, margins, lymph nodes, ER, PR, HER2, and other findings documented in your breast pathology report.
This educational consultation explains your existing written pathology report. It does not provide a new diagnosis, written report, official document, treatment plan, or replacement for your treating clinicians.
Understand what your report documentsAnd what may still depend on surgery, imaging, addenda, or other clinical information.
Board-Certified PathologistProfessional pathology-report guidance
Secure Virtual AppointmentMeet online from the comfort of home
Patient-Friendly ExplanationClear language for complex report findings
Educational SupportNot a replacement for medical advice
Understanding the Process
How a Breast Cancer Diagnosis Is Established
Imaging or examination may identify an area that needs sampling. A pathologist examines the tissue to determine what is present. If surgery follows, the larger specimen and any submitted lymph nodes may provide additional information.
Biopsy
A tissue sample is collected from the area and sent to the pathology laboratory for examination.
Pathology Diagnosis
The pathologist reports whether the tissue is benign, atypical, in situ, or invasive and may identify the tumor type.
Surgical Pathology Report
If surgery is performed, the removed tissue, margins, and submitted lymph nodes can provide a more complete pathologic assessment.
Not every patient follows the same sequence. The available report depends on the procedure performed, the amount of tissue examined, and the stage of evaluation or treatment.
Two Different Reports
Breast Biopsy Versus Surgical Pathology
These reports answer different questions. A biopsy can establish a diagnosis from sampled tissue, while a lumpectomy or mastectomy specimen may provide more complete information about tumor size, margins, and lymph nodes.
Initial Tissue Sample
Breast Biopsy Report
A core needle or other biopsy examines a limited portion of the area seen on imaging or examination.
- Whether the sampled tissue is benign, atypical, in situ, or invasive
- The histologic type or pattern
- Grade when it can be assessed
- Additional stains used to support the diagnosis
- ER, PR, HER2, or other tests when performed
After Surgical Removal
Lumpectomy or Mastectomy Report
A surgical report may examine the tumor, surrounding breast tissue, surgical margins, and submitted lymph nodes.
- Size and extent of invasive cancer and in situ disease
- Histologic type and grade
- Whether surgical margins contain tumor
- How many lymph nodes were examined and involved
- Treatment effect and other documented features
Inside the Report
What Your Breast Pathology Report May Tell You
A breast pathology report contains findings that must be understood together. The available detail depends on the specimen, procedure, prior treatment, and testing performed.
A pathology finding should not be interpreted in isolation.
Tumor type, size, grade, margins, lymph nodes, biomarkers, imaging, and clinical findings may all contribute to the wider assessment.
Diagnosis and Tumor Type
The report may identify ductal carcinoma in situ, invasive carcinoma, or another diagnosis and describe a histologic type or pattern.
In Situ or Invasive
In situ disease remains within the structure where it began, while invasive cancer extends into surrounding breast tissue.
Histologic Grade
For many invasive breast cancers, grade summarizes tubule formation, nuclear features, and mitotic activity.
Tumor Size
A surgical report may document the greatest dimension of invasive cancer and the extent of associated in situ disease.
Surgical Margins
Margins describe the relationship between the diagnosed process and the examined cut edges of the specimen.
Lymph Nodes
The report may state how many nodes were examined, how many contained cancer, and the size or pattern of deposits.
Lymphovascular Invasion
The report may state whether tumor cells are identified within lymphatic channels or blood vessels.
Biomarkers and Addenda
ER, PR, HER2, Ki-67, genomic assays, or additional studies may appear in the main report or later documents.
Need Help Understanding These Findings?
Review the terminology, key findings, limitations, and pending results in your existing breast pathology report during a secure virtual consultation.
Duct or lobuleWhere in situ disease begins
Basement membraneMicroscopic boundary
Breast stromaSurrounding breast tissue
Adjacent tissueWhere tumor extent may be measured
Skin or chest wallWhere applicable
Understanding Tumor Extent
In Situ Disease, Invasive Cancer, and Nearby Structures
These terms describe different relationships between the diagnosed cells and surrounding tissue. They contribute to the pathologic assessment but do not determine the complete clinical stage by themselves.
In Situ Disease
Abnormal cells remain within the duct or lobule and have not invaded surrounding breast stroma in the examined tissue.
Invasive Cancer
Cancer cells extend beyond the structure where they began and into surrounding breast tissue.
Nearby Structures
Where applicable, the report may document involvement of skin, nipple, skeletal muscle, or other submitted tissue.
Additional Pathology Findings
Features Considered With the Wider Clinical Picture
Breast surgical pathology reports may document additional features considered alongside tumor size, lymph nodes, biomarkers, imaging, prior treatment, and other clinical information.
Histologic Grade
Grade describes microscopic differentiation and is not interchangeable with the complete cancer stage.
Lymphovascular Invasion
This means tumor cells are identified within lymphatic channels or blood vessels in the examined tissue.
Lymph-Node Findings
Node reports may describe the number examined, the number involved, and features of any documented tumor deposits.
Surgical Margins
The report may state whether invasive cancer or in situ disease reaches an examined edge and may provide measurements.
Treatment Effect and Other Findings
After systemic therapy, the report may document treatment-related changes in the breast or lymph nodes. Calcifications, multifocality, skin findings, and other observations may also require clinical context.
Biomarker Testing
ER, PR, HER2, and Other Breast Cancer Tests
These tests describe characteristics of the tumor. They may appear in the main report, an addendum, or a separate laboratory document and should be interpreted with the full clinical record.
Hormone Receptors
ER and PR testing evaluates nuclear staining in tumor cells and may include an interpretation, percentage, and staining intensity.
ERPR
HER2 Testing
HER2 may be evaluated by immunohistochemistry and, when applicable, in situ hybridization. Reports may include IHC and ISH findings.
IHCISH
Additional Testing
Ki-67, genomic assays, E-cadherin, or other studies may be documented depending on the diagnosis and clinical setting.
Ki-67Other
Biomarker results do not determine treatment by themselves. Your care team combines the pathology findings with the procedure, stage, health history, and other clinical information. A consultation explains what is documented without recommending therapy.
Questions About ER, PR, HER2, or Other Results?
Get a patient-friendly explanation of the biomarker findings already documented in your pathology report and understand which results may still be pending.
Putting the Results Together
What Is Confirmed, Pending, or Dependent on Other Information?
A pathology report may answer many important questions, but it may not provide the complete picture on its own.
Confirmed in the Report
Documented Pathology Findings
The diagnosis, tumor type, grade, size, margins, lymph-node findings, and additional microscopic features may be documented when the available specimen allows.
May Still Be Pending
Addenda or Additional Testing
ER, PR, HER2, additional stains, genomic assays, outside review, or other results may still be in progress after the first report is issued.
Requires Wider Context
Complete Stage and Treatment Planning
Complete staging and treatment decisions may also require imaging, examination, operative findings, laboratory results, and assessment by the treating care team.
How HONEST Pathology Helps
A Clearer Explanation of the Report You Already Have
A pathology report consultation helps you understand terminology and findings already documented, so you can approach conversations with your treating team with greater context and more focused questions.
Upload Your Report and Records
Submit the pathology report and relevant records requested for the consultation.
Meet Online With a Pathologist
Discuss the report during a private virtual appointment and ask questions about the documented findings.
Receive a Plain-Language Explanation
Better understand the terminology and prepare questions to discuss with your treating care team.
Consultation Scope
What the Consultation Includes and Excludes
A report explanation and a formal microscopic second opinion are different services. Clear boundaries help you choose the appropriate option.
The Consultation May Explain
- The documented diagnosis and histologic terminology
- Differences between biopsy and surgical reports
- In situ versus invasive disease, tumor size, and grade
- Margins and lymph-node findings
- ER, PR, HER2, and other tests already documented
- Findings that remain pending, limited, or included in an addendum
- Questions to discuss with your treating team
The Consultation Does Not Include
- A new pathology diagnosis or replacement interpretation
- A new written report or official document
- Complete staging from the pathology report alone
- Treatment prescribing or replacement of the oncology team
- Genetic counseling or personalized hereditary-risk advice
- Microscopic slide review unless a separate pathology second-opinion service is ordered
Choosing the Right Service
Report Consultation or Formal Pathology Second Opinion?
The right option depends on whether you need help understanding written results or an independent review of pathology slides, tissue, or digital images.
Frequently Asked Questions
Questions About Breast Pathology Reports
These answers provide general educational information. Individual reports vary according to the specimen, procedure, testing, prior treatment, and wider clinical situation.
What information is included in a breast cancer pathology report?
Depending on the procedure, the report may include the diagnosis, tumor type, whether cancer is in situ or invasive, grade, size, margins, lymphovascular invasion, lymph-node findings, ER, PR, HER2, and other test results. Not every item appears in every report.
Why may a surgical report contain more detail than a biopsy?
A biopsy samples a limited area. A lumpectomy or mastectomy can provide more tissue for assessing tumor size, surrounding breast tissue, surgical margins, and any submitted lymph nodes.
What is the difference between in situ and invasive breast cancer?
In situ disease remains within the duct or lobule where it began, while invasive cancer extends into surrounding breast tissue. Your treating team interprets this finding with the complete clinical record.
What do ER and PR results mean?
ER and PR testing evaluates whether tumor-cell nuclei show hormone receptor staining. Reports may include an interpretation, percentage, and intensity. Treatment implications belong with the oncology team.
What does HER2 status mean?
HER2 testing evaluates protein expression or gene amplification. The report may include IHC and, when performed, ISH findings. A consultation can explain the documented result without recommending treatment.
Does the pathology report show the complete cancer stage?
A surgical pathology report may provide pathologic tumor and lymph-node categories, but complete staging may also depend on imaging, examination, operative findings, and other clinical information.
Can my report be explained without reviewing the pathology slides?
Yes. A report consultation can explain the written diagnosis, terminology, grade, margins, lymph nodes, biomarkers, limitations, and pending findings. It does not provide an independent microscopic diagnosis.
When is a formal pathology second opinion more appropriate?
A formal second opinion may be appropriate when findings are complex, uncertain, unexpected, or when an independent examination of the original slides or tissue could provide additional value.
Clearer Answers Begin Here
Understand the Findings in Your Breast Pathology Report
Meet online with a pathologist who can explain the terminology, key findings, biomarker results, and questions raised by your existing report.
Educational support only. This service does not replace your treating physician, oncologist, surgeon, radiologist, genetic counselor, or medical care team.
